Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Klotho Neurosciences, Inc. (GRML : NSDQ)

• Company Description    Klotho Neurosciences Inc. is a pharmaceutical company. It specializes in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system which are seen as key developments in treating neurodegenerative and age-related disorders. Klotho Neurosciences Inc., formerly known as ANEW MEDICAL INC., is based in NEW YORK. Number of Employees: 2

• Price / Volume Information    Yesterday's Closing Price: $0.19 Daily Weekly Monthly 20 Day Moving Average: 9,074,062 shares Shares Outstanding: 138.13 (millions) Market Capitalization: $26.60 (millions) Beta: 7.05 52 Week High: $1.23 52 Week Low: $0.16 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -24.74% -25.33% 12 Week -62.65% -63.56% Year To Date -33.36% -38.45%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1300 SOUTH BOULEVARD UNIT D - CHARLOTTE,NC 28203 USA ph: 833-931-6330 fax: - ir@greenlandmines.com https://greenlandmines.com

• General Corporate Information    Officers Joseph A. Sinkule - Chief Executive Officer Jeffrey LeBlanc - Chief Financial Officer Samuel Zentman - Director Riad El-Dada - Director Jon McGarity - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MINING -MISC Sector: Basic Materials CUSIP: 49876K103 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/17/26 Share - Related Items Shares Outstanding: 138.13 Most Recent Split Date: (:1) Beta: 7.05 Market Capitalization: $26.60 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/17/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.45 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -87.50% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - -109.40 12/31/25 - -139.10 ROA 06/30/26 - - 03/31/26 - -98.80 12/31/25 - -127.39 Current Ratio 06/30/26 - - 03/31/26 - 19.73 12/31/25 - 95.02 Quick Ratio 06/30/26 - - 03/31/26 - 19.73 12/31/25 - 95.02 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - - 03/31/26 - 0.42 12/31/25 - 0.13 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©